Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649
Fig. 2.

Download original image

Fig. 2. Waterfall plots of the best changes in target lesions of the 43 patients with metastatic CRC who received apatinib plus PD-1 blockades treatment.
CRC, colorectal cancer; PD-1, programmed cell death protein 1; PR, partial response; SD, stable disease; PD, progressive disease.
J Cancer Prev 2023;28:106~114
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd